Cancer Rates Are Growing Faster In Africa

Than On Any Other Continent &

Africa Will Surpass All Continents

In Cancer Deaths By Year 2040

CANCER IS A SEVERELY UNADDRESSED EMERGING PUBLIC HEALTH PROBLEM IN AFRICA

People of African ancestry across the globe, whether in Brazil, the Caribbean, United States, Europe, etc. or Africa, are disproportionately affected by cancer. On the Continent, the occurrence of cancer varies remarkably from that of the West. The types of cancer, the stage of diagnosis, the sex of patients, and the age at which patients are diagnosed all differ, with incidence and mortality rates being much higher.

CANCER IN ALL People of African Ancestry

Face higher cancer incidence and mortality rates than any other racial group.

Are more likely to be diagnosed with cancer at later stages; leading to lower survival rates.

Develop certain cancers at an earlier age than other racial groups.

Are overwhelmingly under-represented in cancer research worldwide.

CHALLENGE

REDUCE THE BURDEN OF CANCER IN WEST AFRICA

Many of the major cancer types affecting West Africans are highly treatable when diagnosed early. However, there is no major comprehensive cancer facility within West Africa that’s capable of providing today’s most innovative and effective treatment options currently available in other parts of the world. Further, too many West Africans are needlessly succumbing to cancers that are either preventable or easily identifiable and treatable with early detection.

PROJECT

A PROJECT OF SCIENTIFIC AND ETHICAL RELEVANCE

The first of its kind in West Africa, the Africa Continental Cancer Center and Research Institute in Accra, Ghana is being developed as a world class, state-of-the-art, fully comprehensive cancer center to provide prevention, screening, diagnostic, treatment, palliative and research programs and services for West Africans.

This privately funded, history-making legacy project informed by a partnership of continental and diaspora Africans working in collaboration with US cancer hospital planning advisors, investors, oncology and medical practitioners, clinical researchers, legal advisors, construction partners, architects, engineers, green power generation providers, local government agencies, local and international teaching hospitals & universities, pharmaceutical companies, equipment vendors, cancer support organizations, community and other stakeholders.